PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 32 filers reported holding PHARMACYTE BIOTECH INC in Q2 2022. The put-call ratio across all filers is 6.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $461,194 | +116.4% | 158,486 | +117.1% | 0.00% | – |
| Q4 2022 | $213,160 | -28.5% | 73,000 | -41.2% | 0.00% | – |
| Q3 2022 | $298,000 | -43.1% | 124,124 | -46.5% | 0.00% | – |
| Q2 2022 | $524,000 | +219.5% | 231,809 | +226.2% | 0.00% | – |
| Q1 2022 | $164,000 | +15.5% | 71,062 | +24.7% | 0.00% | – |
| Q4 2021 | $142,000 | +49.5% | 57,000 | +89.4% | 0.00% | – |
| Q3 2021 | $95,000 | – | 30,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,061,411 | $2,378,000 | 1.62% |
| Ayrton Capital LLC | 153,130 | $343,000 | 0.56% |
| Shay Capital LLC | 982,698 | $2,201,000 | 0.44% |
| EQUITEC PROPRIETARY MARKETS, LLC | 342,994 | $768,000 | 0.22% |
| FNY Investment Advisers, LLC | 15,290 | $34,000 | 0.02% |
| K2 PRINCIPAL FUND, L.P. | 91,095 | $204,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 26,200 | $59,000 | 0.00% |
| Aspire Private Capital, LLC | 800 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,758 | $3,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,734 | $4,000 | 0.00% |